Table 21-7.
National Committee for Quality Assurance Health Plan Employer Data and Information Set Measures of Care, 2010
| Commercial, % | Medicare, % | Medicaid, % | |
|---|---|---|---|
| AMI | |||
| β-Blocker persistence* | 75.5 | 83.1 | 76.3 |
| Cholesterol management for patients with cardiovascular disease | |||
| Cholesterol screening | 88.9 | 88.5 | 82.0 |
| LDL cholesterol control (<100 mg/dL) | 59.9 | 56.7 | 42.8 |
| Hypertension | |||
| BP <140/90 mm Hg | 63.4 | 61.9 | 55.6 |
| DM | |||
| HbA1c testing | 89.9 | 90.4 | 82.0 |
| HbA1c>9.0% | 27.3 | 25.9 | 44.0 |
| Eye examination performed | 57.7 | 64.6 | 53.1 |
| LDL cholesterol screening | 85.6 | 87.8 | 74.7 |
| LDL cholesterol <100 mg/dL | 47.7 | 52.1 | 34.6 |
| Monitoring nephropathy | 83.6 | 89.2 | 77.7 |
| BP <140/90 mm Hg | 65.7 | 62.3 | 60.4 |
| Advising smokers and tobacco users to quit | 76.7 | 77.9 | 73.6 |
| BMI percentile assessment in children and adolescents | 35.2 | N/A | 37.3 |
| Nutrition counseling (children and adolescents) | 37.4 | N/A | 45.6 |
| Counseling for physical activity (children and adolescents) | 35.3 | N/A | 36.7 |
| BMI assessment for adults | 40.7 | 50.4 | 42.2 |
| Physical activity discussion in older adults (65 and older) | N/A | 52.3 | N/A |
Values are percentages.
AMI indicates acute myocardial infarction; LDL, low-density lipoprotein; BP, blood pressure; DM, diabetes mellitus; HbA1c, hemoglobin A1c; BMI, body mass index; and N/A, not available or not applicable.
*
β-Blocker persistence: Received persistent β-blocker treatment for 6 months after AMI hospital discharge.